Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

about

Improvements in the Management of Diabetic Nephropathy Endothelin Receptor Antagonists: New Hope for Renal Protection?Endothelin-receptor antagonist can reduce blood pressure in patients with hypertension: a meta-analysis.

P2860

Q28080717-515C9518-B504-4658-AEF5-F04EF867EFF0 Q38525983-D21DD8A9-60E7-4FF1-B34C-7E6613051A9C Q40493852-B0755169-06F6-47D9-B882-3278C31D51E7

P2860

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

Item

http://www.wikidata.org/entity/Q51000648

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@en

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@nl

type

Item

label

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@en

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@nl

prefLabel

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@en

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@nl

P1476

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

@en

P2093

Ji Wang

http://www.w3.org/2001/XMLSchema#string

Jing Li

http://www.w3.org/2001/XMLSchema#string

Ping Fu

http://www.w3.org/2001/XMLSchema#string

Shenju Gou

http://www.w3.org/2001/XMLSchema#string

Wenming Yuan

http://www.w3.org/2001/XMLSchema#string

Yi Li

http://www.w3.org/2001/XMLSchema#string

P2860

Angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists for preventing the progression of diabetic kidney disease

Avosentan reduces albumin excretion in diabetics with macroalbuminuria

The endothelin antagonist atrasentan lowers residual albuminuria in patients with type 2 diabetic nephropathy

Avosentan for overt diabetic nephropathy.

Endothelin, hypertension and chronic kidney disease: new insights.

Mechanisms of progression and regression of renal lesions of chronic nephropathies and diabetes.

Addition of atrasentan to renin-angiotensin system blockade reduces albuminuria in diabetic nephropathy.

Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes

Edema mechanisms in the patient with heart failure and treatment options.

Endothelin receptor selectivity in chronic kidney disease: rationale and review of recent evidence.

P304

459-466

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.1111/NEP.12442

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25753148

http://www.w3.org/2001/XMLSchema#string

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

about

P2860

P2860

Endothelin-receptor antagonists for diabetic nephropathy: A meta-analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698